-
1
-
-
84862696356
-
-
Available at Accessed May 2013
-
Cancer Research UK. 2012. Available at: http://www.cancerresearchuk.org/ cancer-info/cancerstats/types/prostate/mortality/. Accessed May 2013
-
(2012)
Cancer Research UK
-
-
-
2
-
-
0033991685
-
International trends and patterns of prostate cancer incidence and mortality
-
Hsing AW, Tsao L, Devesa SS,. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85: 60-67
-
(2000)
Int J Cancer
, vol.85
, pp. 60-67
-
-
Hsing, A.W.1
Tsao, L.2
Devesa, S.S.3
-
3
-
-
0034051060
-
Rising incidence of prostate cancer in Scotland: Increased risk or increased detection?
-
Brewster DH, Fraser LA, Harris V, Black RJ,. Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int 2000; 85: 463-473
-
(2000)
BJU Int
, vol.85
, pp. 463-473
-
-
Brewster, D.H.1
Fraser, L.A.2
Harris, V.3
Black, R.J.4
-
4
-
-
0037443695
-
Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey
-
Swan J, Breen N, Coates RJ, Rimer BK, Lee NC,. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003; 97: 1528-1540
-
(2003)
Cancer
, vol.97
, pp. 1528-1540
-
-
Swan, J.1
Breen, N.2
Coates, R.J.3
Rimer, B.K.4
Lee, N.C.5
-
5
-
-
2642551798
-
Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: A cross-sectional study
-
Melia J, Moss S, Johns L,. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 2004; 94: 51-56
-
(2004)
BJU Int
, vol.94
, pp. 51-56
-
-
Melia, J.1
Moss, S.2
Johns, L.3
-
6
-
-
80054972161
-
Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
-
Williams N, Hughes LJ, Turner EL, et al. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities. BJU Int 2011; 108: 1402-1408
-
(2011)
BJU Int
, vol.108
, pp. 1402-1408
-
-
Williams, N.1
Hughes, L.J.2
Turner, E.L.3
-
7
-
-
70349941075
-
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005
-
Welch HG, Albertsen PC,. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101: 1325-1329
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 1325-1329
-
-
Welch, H.G.1
Albertsen, P.C.2
-
8
-
-
0010564411
-
Implementation of ICD-10 for mortality data in England and Wales from January 2001
-
Rooney CF, Smith SK,. Implementation of ICD-10 for mortality data in England and Wales from January 2001. Health Stat Q 2000; 8: 41-50
-
(2000)
Health Stat Q
, vol.8
, pp. 41-50
-
-
Rooney, C.F.1
Smith, S.K.2
-
9
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.P.1
Gray, R.J.2
-
10
-
-
70349140531
-
Outcomes of localized prostate cancer following conservative management
-
Lu-Yao GL, Albertsen PC, Moore DF, et al. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302: 1202-1209
-
(2009)
JAMA
, vol.302
, pp. 1202-1209
-
-
Lu-Yao, G.L.1
Albertsen, P.C.2
Moore, D.F.3
-
11
-
-
78650251130
-
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006
-
Abdollah F, Sun M, Thuret R, et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol 2011; 59: 88-95
-
(2011)
Eur Urol
, vol.59
, pp. 88-95
-
-
Abdollah, F.1
Sun, M.2
Thuret, R.3
-
12
-
-
84879673976
-
-
National Cancer Institute, Surveillance, Epidemiology and End Results Available at Accessed May 2013
-
National Cancer Institute, Surveillance, Epidemiology and End Results. 2013. Available at: http://seer.cancer.gov/statfacts/html/prost.html. Accessed May 2013
-
(2013)
-
-
-
13
-
-
70350690484
-
Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer
-
Moore AL, Dimitropoulou P, Lane A, et al. Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. BJU Int 2009; 104: 1592-1598
-
(2009)
BJU Int
, vol.104
, pp. 1592-1598
-
-
Moore, A.L.1
Dimitropoulou, P.2
Lane, A.3
-
14
-
-
0028884197
-
Is the apparent rise in cancer mortality in the elderly real? Analysis of changes in certification and coding of cause of death in England and Wales, 1970-1990
-
Grulich AE, Swerdlow AJ, dos Santos Silva I, Beral V,. Is the apparent rise in cancer mortality in the elderly real? Analysis of changes in certification and coding of cause of death in England and Wales, 1970-1990. Int J Cancer 1995; 63: 164-168
-
(1995)
Int J Cancer
, vol.63
, pp. 164-168
-
-
Grulich, A.E.1
Swerdlow, A.J.2
Dos Santos Silva, I.3
Beral, V.4
-
15
-
-
0035814438
-
Determining cause of death in prostate cancer: Are death certificates valid?
-
Penson DF, Albertsen PC, Nelson PS, Barry M, Stanford JL,. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst 2001; 93: 1822-1823
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1822-1823
-
-
Penson, D.F.1
Albertsen, P.C.2
Nelson, P.S.3
Barry, M.4
Stanford, J.L.5
-
16
-
-
80051778798
-
High accuracy of Swedish death certificates in men participating in screening for prostate cancer: A comparative study of official death certificates with a cause of death committee using a standardized algorithm
-
Godtman R, Holmberg E, Stranne J, Hugosson J,. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm. Scand J Urol Nephrol 2011; 45: 226-232
-
(2011)
Scand J Urol Nephrol
, vol.45
, pp. 226-232
-
-
Godtman, R.1
Holmberg, E.2
Stranne, J.3
Hugosson, J.4
-
17
-
-
0024324367
-
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
-
Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989; 321: 419-424
-
(1989)
N Engl J Med
, vol.321
, pp. 419-424
-
-
Crawford, E.D.1
Eisenberger, M.A.2
McLeod, D.G.3
|